Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.7072
+0.0160 (2.31%)
At close: Jul 14, 2026, 4:00 PM EDT
0.7150
+0.0078 (1.10%)
After-hours: Jul 14, 2026, 7:26 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $190.69 million as of July 14, 2026. Its market cap has decreased by -42.01% in one year.
Market Cap
190.69M
Enterprise Value
208.65M
1-Year Change
-42.01%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $190.69M, an increase of 53.40%. That is a compound annual growth rate of 7.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 190.69M | 2.87% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 194.70M |
| Protalix BioTherapeutics | 192.57M |
| Arcturus Therapeutics Holdings | 190.72M |
| Acumen Pharmaceuticals | 190.68M |
| Outlook Therapeutics | 187.34M |
| Tonix Pharmaceuticals Holding | 186.59M |
| MediWound | 183.14M |
| Alpha Cognition | 182.47M |